Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

计划入组 35 人 · 首次发布于 2015 年 7 月 3 日

Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors

计划入组 35 人 · 首次发布于 2019 年 3 月 14 日

Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)

计划入组 130 人 · 首次发布于 2014 年 4 月 4 日

Cedazuridine(Inqovi 5 Tablet Pack, Inaqovi)

C₉H₁₄F₂N₂O₅

Cytidine

C₉H₁₃N₃O₅

Dioxolane cytidine

FDA Accepts Taiho's Application for INQOVI-Venetoclax Combination in Acute Myeloid Leukemia

BioLineRx Secures Key Patent for GLIX1 Cancer Therapy Covering Over 90% of Cancer Types

Oral Decitabine and Cedazuridine Included in NIH's MyeloMATCH Precision Medicine Trials